Related Experiment Video

Updated: Mar 16, 2026

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

371

INGs are potential drug targets for cancer

Runyun Zhang1,2, Jianhua Jin1, Juanjuan Shi3

  • 1Department of Oncology, Affiliated Wujin People's Hospital, Jiangsu University, Changzhou, 212017, People's Republic of China.

Journal of Cancer Research and Clinical Oncology
|August 22, 2016
PubMed
Abstract

Insights

Inhibitor of Growth (ING) proteins are crucial tumor suppressors that regulate multiple cancer pathways. This review summarizes their role in tumor progression and potential as cancer therapy strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The Inhibitor of Growth (ING) family (ING1-5) comprises type II tumor suppressors.
  • ING proteins are involved in critical cellular processes including proliferation, apoptosis, senescence, and DNA repair.
  • Loss of INGs is observed in various cancers, suggesting their role in tumor development.

Purpose of the Study:

  • To review recent advancements in understanding how ING proteins regulate tumor progression.
  • To consolidate knowledge on the signaling pathways and mechanisms by which INGs exert tumor suppressive functions.

Main Methods:

  • A comprehensive literature search was conducted on studies investigating the role of INGs in tumor progression.
  • Assayed and synthesized findings from relevant scientific publications.

Main Results:

  • Detailed the specific signaling pathways influenced by ING1, ING2, ING3, and ING4 in tumor progression.
  • Elucidated the molecular mechanisms through which INGs mediate tumor suppression.

Conclusions:

  • This review synthesizes the signaling mechanisms of INGs in tumor suppression.
  • Provides insights into potential therapeutic strategies targeting ING proteins for cancer treatment.
Keywords:
Cancer therapyCell signalingINGsTumor suppressors

More Related Videos

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.5K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.9K

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.7K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K